Bullous pemphigoid is a potentially debilitating autoimmune bullous disease presenting with urticarial plaques, subepidermal bullae, erosions, and pruritus, classically in elderly individuals. This ...

Bullous pemphigoid is the most common autoimmune blistering skin disease of the elderly. Because elderly people have low tolerance for standard regimens of oral corticosteroids, we studied whether ...

Use of certain dipeptidyl peptidase 4 (DPP-4) inhibitors appears to be associated with a small but significantly elevated risk for developing the chronic blistering skin condition bullous pemphigoid, ...

bullous pemphigoid leg The relationship between bullous pemphigoid and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Regardless of the diagnosis of type 2 diabetes, patients with bullous ...

Dupixent is the first and only targeted therapy to receive FDA approval for bullous pemphigoid. FDA approves first targeted therapy for bullous pemphigoid (BP): Dupixent (dupilumab) becomes the first ...

Pemphigoid is a family of rare autoimmune conditions that causes blistering and rashes on the skin and mucous membranes. The body mistakenly sends antibodies to bind to cells in the skin. These ...

Swab the lesions for bacterial and viral cultures. Initiate a sepsis workup and start antibiotics. Do a skin biopsy and treat the lesions with chlorhexidine. Prescribe corticosteroids. Because this ...

This is a rare autoimmune skin disorder that occurs when your immune system starts attacking healthy epidermis cells (the top layer of your skin). Pemphigus can manifest itself as blisters and sores ...

Bullous pemphigoid is a rare autoimmune disease that affects your skin. It’s a chronic disease that causes itchy, fluid-filled blisters to form all over your body. Although people of all ages, ...

Bullous pemphigoid is an autoimmune disease that causes painful chronic blisters and welts. The condition is rare, and typically affects older adults. Sufferers' average age is 80 and usually already ...